Mu Therapeutics Inc.
Austin, TX · Biotech · Private
6β-naltrexol (6BN), a peripherally-selective mu-opioid receptor antagonist molecule for preventing neonatal abstinence syndrome in fetuses of opioid-dependent pregnant women
- Grants
- $2.8M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Development of a Neonatal Abstinence Syndrome Therapy | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Neonatal Abstinence Syndrome Therapy | $1,148,201 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Neonatal Abstinence Syndrome Therapy | $1,276,451 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Neonatal Abstinence Syndrome Therapy | $128,250 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1112 | DiaMedica Therapeutics Inc. | — | $110M |
| 1113 | JUN INNOVATIONS INC | — | — |
| 1114 | COMPANION SCIENCES, INC. | — | — |
| 1115 | Mu Therapeutics Inc. | — | — |
| 1116 | OPERATIONAL TECHNOLOGIES CORPORATION | — | — |
| 1117 | NUTRASORB LLC | — | — |
| 1118 | FGF Therapeutics INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.